Chronic hepatitis C with normal aminotransferase levels: A clinical histologic study

American Journal of Gastroenterology

Volumn 92, Issue 10, 1997, Pages 1788-1792

  Gholson, Charles F ^a,b   Morgan, Kelly ^a,b   Catinis, George ^a,b   Favrot, Dana ^a,b   Taylor, Barbara ^a,b   Gonzalez, Enrique ^a,b   Balart, Luis ^a,b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RNA ANALYSIS;

ADULT; AGED; ALANINE TRANSAMINASE; BIOPSY, NEEDLE; ENZYME TESTS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0030804615     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359-62.
2. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-4.
3. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994;19:1513-20.
4. Batts KP, Ludwig J. Chronic hepatitis: An update on terminology and reporting. Am J Surg Pathol 1995;19:1409-17.
5. International Working Party. Terminology of chronic hepatitis. Am J Gastroenterol 1995;90:181-9.
6. Yano M, Kumada H, Kage M, et al. The long-term pathological evaluation of chronic hepatitis C. Hepatology 1996;23:1334-40.
7. Alberti A, Morsica G, Chemello L, et al. Hepatitis C viremia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992;340: 697-8.
8. Dienstag J. Non-A, non-B hepatitis I. Recognition, epidemiology and clinical features. Gastroenterology 1983;85:439-62.
9. Prieto M, Olaso V, Verdu C, et al. Does the healthy hepatitis C carrier state really exist? An analysis using polymerase chain reaction. Hepatology 1995;22:413-7.
10. Brilliante S, Foli M, Gaiani S, et al. Persistent hepatitis C viraemia without liver disease. Lancet 1993;341:464-5.
11. Shakil AO, Conry-Cantilena C, Alter HJ, et al. Volunteer blood donors with antibody to hepatitis C virus: Clinical, biochemical, virologic and histologic features. Ann Intern Med 1995;123:330-7.
12. Wrobelewski F, LaDue JS. Serum glutamic oxaloacetic transaminase activity as an index of liver cell injury. Ann Intern Med 1955;43:345-60.
13. Kannen A, Wroblewski F. The clinical significance of transaminase activities in serum. Am J Med 1959;27:911-23.
14. Wroblewski F. The clinical significance of transaminase activities in serum. Am J Med 1959;27:911-23.
15. Bang NU, Ruegsegger P, Ley AB, et al. Detection of hepatitis carriers by serum glutamic oxaloacetic transaminase activity. JAMA 1959;171: 2303-6.
16. Aach RD, Szmuness W, Mosley JW, et al. Serum alanine aminotransferase of donors in relation to risk of non-A, non-B hepatitis in recipients. The transfusion-transmitted virus study. N Engl J Med 1981;304:989-94.
17. Hardiman RP, Shaw DR, La Brooy JT, et al. Chronic liver disease in asymptomatic hepatitis C antibody positive blood donors. Aust NZ J Med 1993;23:176-80.
18. Morales TG, Sampliner RE, Bhattacaryya A, et al. Liver histology in anti-HCV positive persons with normal or minimally elevated aminotransferases. J Clin Gastroenterol 1995;21:301-5
19. Naito M, Hayashi N, Hagiwara H, et al. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Hepatology 1994;19:871-5.
20. Rofail MZ, Lewis JH, Fry SW, et al. Interferon (IFN) treatment of patients with chronic hepatitis C (HCV) infection with mildly elevated serum liver enzymes. Gastroenterology 1995;108:A1156 (abstract).
21. Serfaty L, Chazouilleres O, Pawlotsky J-M, et al. Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity. Gastroenterology 1996;110:291-5.
22. Monolio TA, Burke GL, Savage PJ, et al. Sex- and race-related differences in liver-associated serum chemistry tests in young adults in the CARDIA study. Clin Chem 1992;38:1853-9.
23. Hoofnagle JH, Shafritz DA, Popper H. Chronic type B hepatitis and the "healthy" HBsAg carrier state. Hepatology 1987;7:758-63.
24. Sangiovanni A, Spinzi GC, Morales R, et al. Natural history of HCV-Ab positive patients with persistently normal transaminases. Gastroenterology 1996;110:A587.
25. Koff RS, Dienstag JL. Extrahepatic manifestations of hepatitis C and association with alcoholic liver disease. Semin Liver Dis 1995;15: 101-9.
26. McCarthy M, Wiley TE, Breidi L, et al. Alcohol is an independent risk factor in the progression of HCV-induced liver disease. Gastroenterology 1996;110:A1263.
27. Fong T-L, Kanel GC, Conrad A, et al. Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. Hepatology 1984;19:554-7.